ADPT — Adaptive Biotechnologies Corp

Price
$27.98
Change
+1.15 (+4.29%)
Open
$26.98
High
$28.27
Low
$26.54
Prev close
$26.83
Volume
3.3M

The ticker ADPT represents Adaptive Biotechnologies Corp, listed on NASDAQ.

ADPT belongs to the HEALTHCARE sector and the DIAGNOSTICS & RESEARCH industry.

To answer "what is ADPT worth" or "what is happening with Adaptive Biotechnologies Corp", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.

VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.

What ADPT is

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.…

Adaptive Biotechnologies Corp is classified under HEALTHCARE, in the DIAGNOSTICS & RESEARCH industry.

It trades on NASDAQ as a common stock.

ADPT size and valuation

At roughly $4.29B, ADPT is a mid-cap.

Earnings per share are negative at -0.41, so there is no meaningful price-to-earnings multiple to quote.

Beta is 2.10: historically it has moved more than the market.

ADPT over the past year

Over the past year ADPT has traded between $12.00 and $30.74, and the current price sits at 85% of that range.

Near the top of its 52-week range, the stock is close to the best price it has carried in a year.

The 50-day average is $25.74 against a 200-day average of $18.73 — the shorter average sits above the longer one, the configuration usually read as an uptrend.

The published analyst target is $28.31, within a couple of percent of the current price. A target is an aggregate of opinions, not a measurement.

How Adaptive Biotechnologies Corp (ADPT) is trading

Adaptive Biotechnologies Corp (ADPT) is up 4.29% at $27.98 — a more volatile session than average.

The session ranged from $26.54 to $28.27 — 6.2% of the share price — and the current price sits at 83% of that range.

It opened at 25% of the daily range and finished at 83% of it: ADPT turned around inside the session, in the buyers' favour.

Volume ran near 3.3M shares, about $93.3M of stock changing hands.

Traded alongside ADPT

Names traded alongside ADPT in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).

What VAQO's model says about ADPT

Two statistical models run over ADPT inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.

ADPT at a glance

  • Symbol: ADPT
  • Name: Adaptive Biotechnologies Corp
  • Sector: HEALTHCARE
  • Industry: DIAGNOSTICS & RESEARCH
  • Exchange: NASDAQ
  • Instrument: Stock

ADPT — frequently asked questions

What is the market cap of ADPT?

Adaptive Biotechnologies Corp has a market capitalisation of roughly $4.29B.

What is the 52-week range for ADPT?

ADPT has traded between $12.00 and $30.74 over the past year, with the current price at 85% of that range.

How much does ADPT stock cost today?

Adaptive Biotechnologies Corp (ADPT) trades at $27.98, a change of +4.29% in the latest session.

Is ADPT up or down today?

ADPT is up 4.29% in the latest session, at $27.98.

What is the daily trading range for ADPT?

ADPT traded between $26.54 and $28.27 in the latest session, and currently trades at $27.98.

What is the trading volume for ADPT?

ADPT traded roughly 3.3M shares in the latest session.

Which exchange is ADPT listed on?

ADPT is listed on NASDAQ, in the HEALTHCARE sector.

Should I buy ADPT stock?

VAQO gives no buy or sell recommendations and is not an investment adviser. The ADPT figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.

Traded alongside ADPT

← All stocks on VAQO

Last updated: 2026-11-08